Portal:CPTAC/Hallmarks
From WikiPathways
(Difference between revisions)
Current revision (18:59, 5 October 2017) (view source) (added Therapeutics category) |
|||
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| - | {| style="margin: 10px; background-color:#eaf2ee" | + | {| style="width:100%; margin: 10px; background-color:#eaf2ee" |
|width=100px; cell padding=50px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Proliferative|<big><u><b>Sustaining proliferative signaling</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}} | |width=100px; cell padding=50px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Proliferative|<big><u><b>Sustaining proliferative signaling</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}} | ||
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Growth|<big><u><b>Evading growth suppressors</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Growth}} | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Growth|<big><u><b>Evading growth suppressors</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Growth}} | ||
| Line 11: | Line 11: | ||
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Instability|<big><u><b>Genome instability and mutation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Instability}} | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Instability|<big><u><b>Genome instability and mutation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Instability}} | ||
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Inflammation|<big><u><b>Tumor promoting inflammation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Inflammation}} | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Inflammation|<big><u><b>Tumor promoting inflammation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Inflammation}} | ||
| + | |- | ||
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Avoiding|<big><u><b>Avoiding immune destruction</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Avoiding}} | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Avoiding|<big><u><b>Avoiding immune destruction</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Avoiding}} | ||
| + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Therapeutics|<big><u><b>Therapeutics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Therapeutics}} | ||
|} | |} | ||
Current revision
| Sustaining proliferative signaling
Ras signaling (Homo sapiens) Image does not exist Ras signaling | Evading growth suppressors
Tumor suppressor activity of SMARCB1 (Homo sapiens) Image does not exist Tumor suppressor activity of SMARCB1 | Activating invasion and metastasis
Focal adhesion: PI3K-Akt-mTOR-signaling (Homo sapiens) Image does not exist Focal adhesion: PI3K-Akt-mTOR-signaling |
| Enabling replicative immortality
Wnt signaling, NetPath (Homo sapiens) Image does not exist Wnt signaling, NetPath | Inducing angiogenesis
Angiogenesis (Homo sapiens) Image does not exist Angiogenesis | Resisting cell death
Apoptosis (Homo sapiens) Image does not exist Apoptosis |
| Deregulating cellular energetics
Hereditary leiomyomatosis and renal cell carcinoma pathway (Homo sapiens) Image does not exist Hereditary leiomyomatosis and renal cell carcinoma pathway | Genome instability and mutation
DNA IR-double strand breaks and cellular response via ATM (Homo sapiens) Image does not exist DNA IR-double strand breaks and cellular response via ATM | Tumor promoting inflammation
IL1 signaling (Homo sapiens) Image does not exist IL1 signaling |
| Avoiding immune destruction
Interferon type I signaling (Homo sapiens) Image does not exist Interferon type I signaling | Therapeutics
Imatinib and chronic myeloid leukemia (Homo sapiens) Image does not exist Imatinib and chronic myeloid leukemia |

